These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2966608)

  • 41. Tissue fluid penetration and anti-treponemal activity of trospectomycin (a new spectinomycin analog) in the rabbit syphilis model.
    Rice RJ; Thompson SE; Arko RJ; Hunter EF; Burleigh PM; Craig BT; Larsen SA
    Sex Transm Dis; 1988; 15(3):152-5. PubMed ID: 2976206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
    Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R
    J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
    Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
    J Clin Microbiol; 1992 Mar; 30(3):744-5. PubMed ID: 1313052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.
    Debets-Ossenkopp YJ; Namavar F; MacLaren DM
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):353-5. PubMed ID: 7649202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
    Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agar dilution method for susceptibility testing of Neisseria gonorrhoeae.
    de Castillo MC; de Saab OA; de Fernandez NP; de Nader OM; de Ruiz Holgado AP
    Mem Inst Oswaldo Cruz; 1996; 91(6):789-93. PubMed ID: 9283668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spenolimycin, a new spectinomycin-type antibiotic. III. Biological properties.
    Fernandes PB; Vojtko CM; Bower RR; Weisz J
    J Antibiot (Tokyo); 1984 Dec; 37(12):1525-7. PubMed ID: 6241193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonization.
    Khardori N; Wong E; Nguyen H; Jeffery-Wiseman C; Wallin E; Tewari RP; Bodey GP
    J Infect Dis; 1991 Jul; 164(1):108-13. PubMed ID: 1829103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
    Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
    J Clin Microbiol; 1992 Jan; 30(1):225-6. PubMed ID: 1310329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.
    Rompalo AM; Colletta L; Caine VA; Linnemeier P; Neumann T; Hook EW; Jones RB
    Sex Transm Dis; 1994; 21(4):213-6. PubMed ID: 7974072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro drug susceptibility of Chlamydia sp. strain TWAR.
    Kuo CC; Grayston JT
    Antimicrob Agents Chemother; 1988 Feb; 32(2):257-8. PubMed ID: 2966609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The in vitro antibacterial activity of nine aminoglycosides and spectinomycin on clinical isolates of common Gram-negative bacteria.
    Phillips I; Eykyn S; King BA; Jenkins C; Warren CA; Shannon KP
    J Antimicrob Chemother; 1977 Sep; 3(5):403-10. PubMed ID: 143468
    [No Abstract]   [Full Text] [Related]  

  • 55. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
    Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
    Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
    King A; Boothman C; Phillips I
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):677-85. PubMed ID: 2226498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
    Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
    Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.